Inventor · disambiguated record
Kerry Fisher
Also filed as: FISHER KERRY · FISHER KERRY DAVID
10 granted patents·10 pending applications·26 citations·filing 1999–2024
84Inventor score
Files withAKAMIS BIO LTD6PSIOXUS THERAPEUTICS LTD5UNIV OXFORD INNOVATION LTD3ANTHONY DANIEL1DAVIS BENJAMIN GUY1
Top patents by PatentIndex Score
20 records- 0186US2025090658A1Polymer adjuvantUNIV OXFORD INNOVATION LTD·Filed 2024·Application pending·0 cites
- 0284US9987314B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Jun 5, 2018·6 cites·23 claims
- 0382US8815563B2Modified virusDAVIS BENJAMIN GUY·Filed 2005·Granted Aug 26, 2014·8 cites·12 claims
- 0481US11439678B2Oncolytic adenoviruses armed with heterologous genesPSIOXUS THERAPEUTICS LTD·Filed 2018·Granted Sep 13, 2022·1 cites·27 claims
- 0580US2024325472A1Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 0675US2025026851A1Adenovirus armed with bispecific t cell activatorAKAMIS BIO LTD·Filed 2024·Application pending·0 cites
- 0771US11938159B2Oncolytic adenoviruses armed with heterologous genesAKAMIS BIO LTD·Filed 2020·Granted Mar 26, 2024·0 cites·10 claims
- 0864US12350302B2Dosing regime and formulations for type B adenovirusesAKAMIS BIO LTD·Filed 2021·Granted Jul 8, 2025·0 cites·20 claims
- 0961US2021000934A1Polymer adjuvantUNIV OXFORD INNOVATION LTD·Filed 2020·Application pending·0 cites
- 1059US11173186B2Dosing regime and formulations for type B adenovirusPSIOXUS THERAPEUTICS LTD·Filed 2014·Granted Nov 16, 2021·0 cites·19 claims
- 1157US12258417B2Adenovirus armed with bispecific T cell engagerAKAMIS BIO LTD·Filed 2017·Granted Mar 25, 2025·0 cites·23 claims
- 1257US12049513B2Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engagerAKAMIS BIO LTD·Filed 2017·Granted Jul 30, 2024·0 cites·26 claims
- 1355US2011243939A1Modification of nucleic acid vectors with polymers comprising charged quaternary amino groupsSEYMOUR LEONARD WILLIAM·Filed 2009·Application pending·0 cites
- 1454US2017304420A1Polymer adjuvantUNIV OXFORD INNOVATION LTD·Filed 2015·Application pending·0 cites
- 1552US2017112923A1Multi-valent adjuvant displayPSIOXUS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 1647US7279318B1Modification of biological elementsHYBRID SYSTEMS LTD·Filed 1999·Granted Oct 9, 2007·11 cites·35 claims
- 1747US2016090574A1A process for the production of adenovirusPSIOXUS THERAPUETICS LTD·Filed 2014·Application pending·0 cites
- 1844US2012141409A1Multi-valent adjuvant displaySEYMOUR LEONARD CHARLES WILLIAM·Filed 2010·Application pending·0 cites
- 1937US2017073647A1Process for the preparation of group b adenovirusesPSIOXUS THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 2030US11744877B2Method for permeabilizing tumor vasculature using a tumor vasculature permeabilizing molecule to improve access of a therapeutic or diagnostic agent to a tumorANTHONY DANIEL·Filed 2010·Granted Sep 5, 2023·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Kerry Fisher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →